The U.S. healthcare landscape is in a transformative phase. The rapid surge of GLP-1 obesity drugs and persistent discussions around ivermectin and GLP-1 healthcare discussions represent a clash of priorities in modern medicine. At the same time, the telehealth boom is changing how Americans access care, raising complex questions about health privacy,...